2022
respiratory webcast series
2022 Respiratory Webcast Series REGISTER HERE
We are pleased to offer a series of respiratory webcasts discussing the latest treatment options for asthma and COPD management, encompassing the latest recommendations from the Asthma and Respiratory Foundation NZ. Throughout the year, this webcast series will focus on the implications of the latest treatment recommendations for practitioners and patients amid the ongoing challenges of COVID-19. Find out more about the next event in the series and register by clicking on the link below.
What can we learn from a secondary care Asthma Audit in NZ? With Dr James Fingleton
Thursday, 3rd March, 2022 at 6:30 pm (45 minutes + questions)
Dr James Fingleton Medical director of Asthma and Respiratory foundation NZ Respiratory physician at Wellington Hospital, Chief Investigator of the TSANZ NZ National Asthma Audit
Dr James Fingleton is a respiratory physician at Wellington Hospital, with a sub-specialist interest in asthma. He is currently President of the Thoracic Society of Australia New Zealand (TSANZ) NZ branch and Chief Investigator of the TSANZ NZ National Asthma Audit. James also serves as Medical Director of the Asthma and Respiratory Foundation New Zealand and teaches as a Senior Clinical Lecturer at the University of Otago, Wellington.
To Register, Please Scan
or
CLICK HERE
This webcast has been initiated, organised and funded by AstraZeneca. The content is intended for registered HealthCare Professionals for educational purposes. The company seeks no commitment from external stakeholders to take any action as a result of the invitation or related support. PRIVACY STATEMENT: Your personal information (“Information”) will be collected and used by AstraZeneca Pty Ltd (“AstraZeneca”) for the purpose of administration of the webcast, for follow-up purposes and for any other purpose described in AstraZeneca’s Privacy Policy (see below for link). AstraZeneca may disclose your Information to third parties such as our related entities or service providers (including IT support/ service providers), some of which may be located overseas including in the US, European Union and Asia Pacific. Please refer to our Privacy Policy (https://www.astrazeneca.com.au/ privacy-policy.html) for more information about how your Information is handled and how you may seek to access or correct your Information. If you have any queries about how we handle your personal information, please write to: Privacy Officer, AstraZeneca, PO Box 131, North Ryde, NSW, 1670, Australia or email to: privacy.au@astrazeneca.com. AstraZeneca Limited, PO Box 87453, Meadowbank, Auckland 1742. For Medical Information enquiries or to report an adverse event or product quality complaint: Telephone (09) 306 5650 or via https://contactazmedical.astrazeneca.com Or email Medical Information enquiries to medinfo.nz@astrazeneca.com. NZ-1589, TAPS NA 13543, E-012378, February 2022.